These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 21285295

  • 1. MG53 participates in ischaemic postconditioning through the RISK signalling pathway.
    Zhang Y, Lv F, Jin L, Peng W, Song R, Ma J, Cao CM, Xiao RP.
    Cardiovasc Res; 2011 Jul 01; 91(1):108-15. PubMed ID: 21285295
    [Abstract] [Full Text] [Related]

  • 2. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway.
    Lacerda L, Somers S, Opie LH, Lecour S.
    Cardiovasc Res; 2009 Nov 01; 84(2):201-8. PubMed ID: 19666677
    [Abstract] [Full Text] [Related]

  • 3. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
    Ruze A, Chen BD, Liu F, Chen XC, Gai MT, Li XM, Ma YT, Du XJ, Yang YN, Gao XM.
    Clin Sci (Lond); 2019 Mar 15; 133(5):665-680. PubMed ID: 30804219
    [Abstract] [Full Text] [Related]

  • 4. Cardiac mGluR1 metabotropic receptors in cardioprotection.
    Vincent A, Sportouch C, Covinhes A, Barrère C, Gallot L, Delgado-Betancourt V, Lattuca B, Solecki K, Boisguérin P, Piot C, Nargeot J, Barrère-Lemaire S.
    Cardiovasc Res; 2017 May 01; 113(6):644-655. PubMed ID: 28453728
    [Abstract] [Full Text] [Related]

  • 5. Cardiac Ischemic Preconditioning Promotes MG53 Secretion Through H2O2-Activated Protein Kinase C-δ Signaling.
    Shan D, Guo S, Wu HK, Lv F, Jin L, Zhang M, Xie P, Wang Y, Song Y, Wu F, Lan F, Hu X, Cao CM, Zhang Y, Xiao RP.
    Circulation; 2020 Sep 15; 142(11):1077-1091. PubMed ID: 32677469
    [Abstract] [Full Text] [Related]

  • 6. MG53 constitutes a primary determinant of cardiac ischemic preconditioning.
    Cao CM, Zhang Y, Weisleder N, Ferrante C, Wang X, Lv F, Zhang Y, Song R, Hwang M, Jin L, Guo J, Peng W, Li G, Nishi M, Takeshima H, Ma J, Xiao RP.
    Circulation; 2010 Jun 15; 121(23):2565-74. PubMed ID: 20516375
    [Abstract] [Full Text] [Related]

  • 7. Essential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection.
    Wang Y, Wang X, Jasmin JF, Lau WB, Li R, Yuan Y, Yi W, Chuprun K, Lisanti MP, Koch WJ, Gao E, Ma XL.
    Arterioscler Thromb Vasc Biol; 2012 Apr 15; 32(4):934-42. PubMed ID: 22328772
    [Abstract] [Full Text] [Related]

  • 8. Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor.
    Lemckert FA, Bournazos A, Eckert DM, Kenzler M, Hawkes JM, Butler TL, Ceely B, North KN, Winlaw DS, Egan JR, Cooper ST.
    Cardiovasc Res; 2016 May 15; 110(2):178-87. PubMed ID: 26790476
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia/reperfusion injury.
    Penna C, Brancaccio M, Tullio F, Rubinetto C, Perrelli MG, Angotti C, Pagliaro P, Tarone G.
    Basic Res Cardiol; 2014 Jul 15; 109(4):418. PubMed ID: 24859929
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. p55γ degrades RIP3 via MG53 to suppress ischaemia-induced myocardial necroptosis and mediates cardioprotection of preconditioning.
    Li Z, Dai R, Chen M, Huang L, Zhu K, Li M, Zhu W, Li Y, Xie N, Li J, Wang L, Lan F, Cao CM.
    Cardiovasc Res; 2023 Nov 15; 119(14):2421-2440. PubMed ID: 37527538
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA, Hartley S, Van Wyk J, Marais E, Lochner A.
    Cardiovasc Drugs Ther; 2006 Feb 15; 20(1):13-25. PubMed ID: 16552474
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gα(i2)-mediated protection from ischaemic injury is modulated by endogenous RGS proteins in the mouse heart.
    Waterson RE, Thompson CG, Mabe NW, Kaur K, Talbot JN, Neubig RR, Rorabaugh BR.
    Cardiovasc Res; 2011 Jul 01; 91(1):45-52. PubMed ID: 21349876
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stat5-dependent cardioprotection in late remote ischaemia preconditioning.
    Chen H, Jing XY, Shen YJ, Wang TL, Ou C, Lu SF, Cai Y, Li Q, Chen X, Ding YJ, Yu XC, Zhu BM.
    Cardiovasc Res; 2018 Apr 01; 114(5):679-689. PubMed ID: 29365089
    [Abstract] [Full Text] [Related]

  • 19. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
    Vigneron F, Dos Santos P, Lemoine S, Bonnet M, Tariosse L, Couffinhal T, Duplaà C, Jaspard-Vinassa B.
    Cardiovasc Res; 2011 Apr 01; 90(1):49-56. PubMed ID: 21233250
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.